Cancer cells enhance their glutamine uptake by expressing glutamine transport proteins such as Alanine-Serine-Cysteine Transporter 2 (ASCT2) and System A Sodium-Coupled Neutral Amino Acid Transporter 2 (SN2). This evidence concerns the gene SLC1A5 and cancer.